Project Grant R61DA064704
Award Date 4/1/26
Completion Date 3/31/27
Dollars Obligated $449K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Baltimore, MD 21201, USA
Similar Awards
- Federal Project Grant Award Summary The National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), awarded $709,085 to the University of Colorado-Denver for an implementation research trial commencing April 1, 2026, and concluding January 31, 2031. This project delivers implementation facilitation services and clinical intervention support designed to expand in-hospital opioid treatment program (OTP) intakes for hospitalized patients with opioid...
- Federal Project Grant Award Summary The National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), awarded $744,728 to The Leland Stanford Junior University for a two-year project period (April 1, 2026 through March 31, 2028) to develop and test family engagement strategies during early substance use disorder (SUD) treatment. The project delivers a multiphase research initiative designed to identify, evaluate, and optimize interventions that...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded McLean Hospital Corporation a $453,654 project grant under the Drug Use and Addiction Research Programs (CFDA 93.279) beginning March 15, 2026, with completion targeted for February 28, 2028. The Recovery Inspired Support Engagement (RISE) initiative develops evidence-based interventions and implementation strategies specifically targeting support persons (family members, friends, and other loved ones) of individuals...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded a $742,500 Project Grant (R34) to Massachusetts General Hospital on July 15, 2025, under the Drug Use and Addiction Research Programs (CFDA 93.279). This three-year pilot study, concluding June 30, 2028, will develop and test a peer recovery coaching intervention designed to promote tobacco abstinence in individuals with concurrent opioid use disorder and tobacco use disorder (MOUD-TUD). The project will adapt an...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded Weill Medical College of Cornell University a $1.74 million Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct a rigorous mixed-methods study evaluating the impact of peer support services (PSS) on treatment engagement and adverse events for Medicaid beneficiaries with substance use disorder. The award, effective September 15, 2025, through July 31, 2030, addresses a critical...
- Federal Project Grant Award Summary The Medical University of South Carolina received a $182,249 Project Grant from the National Institute on Drug Abuse under the Drug Use and Addiction Research Programs (CFDA 93.279) effective July 15, 2025, through June 30, 2029. This award supports the implementation and evaluation of EMPWR (Empowering Pregnant Women Receiving Medications for Opioid Use Disorder), a digitally enhanced intervention designed to improve buprenorphine treatment retention among...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded the University of Washington a $1.447 million Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to optimize opioid use disorder (OUD) treatment interventions within the Washington State Prison System. The award, dated September 15, 2025, with completion targeted for May 31, 2030, funds research to develop and validate practical, scalable strategies for identifying OUD in correctional...
- Federal Project Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded The Johns Hopkins University a K01 Career Development Award totaling $197,624 (awarded April 15, 2026, with completion targeted for March 31, 2031) under the Drug Use and Addiction Research Programs (CFDA 93.279). Under this award, Dr. Lauren Dayton will conduct an exploratory sequential mixed-methods study designed to identify and leverage social network dynamics to improve treatment engagement and...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded Biomotivate LLC a $613,744 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to develop and evaluate the PEACE Platform (Personalized Evocative Audiovisual Content for Everyone), a precision medicine tool designed to support emotional regulation and resilience in individuals with opioid use disorders (OUDs). The platform combines generative artificial intelligence, predictive analytics,...
- Summary of Federal Project Grant Award The University of Kentucky Research Foundation received a $422,921 Project Grant from the National Institute on Drug Abuse under the Drug Use and Addiction Research Programs (CFDA 93.279), awarded on March 1, 2026, with completion targeted for February 28, 2027. The grant funds the STAR (Support Towards Addiction Recovery) Project, which develops and tests an innovative dyadic intervention designed to improve recovery outcomes for individuals with substance...